Global Exosome Diagnostics and Therapeutics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Exosome Diagnostics and Therapeutics market size was valued at US$ 96.1 million in 2023. With growing demand in downstream market, the Exosome Diagnostics and Therapeutics is forecast to a readjusted size of US$ 836.5 million by 2030 with a CAGR of 36.2% during review period.
The research report highlights the growth potential of the global Exosome Diagnostics and Therapeutics market. Exosome Diagnostics and Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Exosome Diagnostics and Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Exosome Diagnostics and Therapeutics market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Exosome Diagnostics and Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Exosome Diagnostics and Therapeutics market. It may include historical data, market segmentation by Type (e.g., Instrument, Reagent), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Exosome Diagnostics and Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Exosome Diagnostics and Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Exosome Diagnostics and Therapeutics industry. This include advancements in Exosome Diagnostics and Therapeutics technology, Exosome Diagnostics and Therapeutics new entrants, Exosome Diagnostics and Therapeutics new investment, and other innovations that are shaping the future of Exosome Diagnostics and Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Exosome Diagnostics and Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Exosome Diagnostics and Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Exosome Diagnostics and Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Exosome Diagnostics and Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Exosome Diagnostics and Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Exosome Diagnostics and Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Exosome Diagnostics and Therapeutics market.
Market Segmentation:
Exosome Diagnostics and Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Exosome Diagnostics and Therapeutics market size was valued at US$ 96.1 million in 2023. With growing demand in downstream market, the Exosome Diagnostics and Therapeutics is forecast to a readjusted size of US$ 836.5 million by 2030 with a CAGR of 36.2% during review period.
The research report highlights the growth potential of the global Exosome Diagnostics and Therapeutics market. Exosome Diagnostics and Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Exosome Diagnostics and Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Exosome Diagnostics and Therapeutics market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Exosome Diagnostics and Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Exosome Diagnostics and Therapeutics market. It may include historical data, market segmentation by Type (e.g., Instrument, Reagent), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Exosome Diagnostics and Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Exosome Diagnostics and Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Exosome Diagnostics and Therapeutics industry. This include advancements in Exosome Diagnostics and Therapeutics technology, Exosome Diagnostics and Therapeutics new entrants, Exosome Diagnostics and Therapeutics new investment, and other innovations that are shaping the future of Exosome Diagnostics and Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Exosome Diagnostics and Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Exosome Diagnostics and Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Exosome Diagnostics and Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Exosome Diagnostics and Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Exosome Diagnostics and Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Exosome Diagnostics and Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Exosome Diagnostics and Therapeutics market.
Market Segmentation:
Exosome Diagnostics and Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Instrument
- Reagent
- Software
- Diagnostic
- Therapeutic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Aethlon Medical(US)
- Exosome Diagnostics(US)
- NanoSomix Inc.(US)
- Thermo Fisher Scientific (US)
- Malvern Instruments (UK)
- System Biosciences(US)
- NX Pharmagen (US)
- Sistemic Inc(UK)
- Capricor Therapeutics (US)
- Exiqon A/S (Denmark)
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Exosome Diagnostics and Therapeutics Market Size 2019-2030
2.1.2 Exosome Diagnostics and Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Exosome Diagnostics and Therapeutics Segment by Type
2.2.1 Instrument
2.2.2 Reagent
2.2.3 Software
2.3 Exosome Diagnostics and Therapeutics Market Size by Type
2.3.1 Exosome Diagnostics and Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Exosome Diagnostics and Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Exosome Diagnostics and Therapeutics Segment by Application
2.4.1 Diagnostic
2.4.2 Therapeutic
2.5 Exosome Diagnostics and Therapeutics Market Size by Application
2.5.1 Exosome Diagnostics and Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Exosome Diagnostics and Therapeutics Market Size Market Share by Application (2019-2024)
3 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Exosome Diagnostics and Therapeutics Market Size Market Share by Players
3.1.1 Global Exosome Diagnostics and Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Exosome Diagnostics and Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Exosome Diagnostics and Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 EXOSOME DIAGNOSTICS AND THERAPEUTICS BY REGIONS
4.1 Exosome Diagnostics and Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Exosome Diagnostics and Therapeutics Market Size Growth (2019-2024)
4.3 APAC Exosome Diagnostics and Therapeutics Market Size Growth (2019-2024)
4.4 Europe Exosome Diagnostics and Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Exosome Diagnostics and Therapeutics Market Size by Country (2019-2024)
5.2 Americas Exosome Diagnostics and Therapeutics Market Size by Type (2019-2024)
5.3 Americas Exosome Diagnostics and Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Exosome Diagnostics and Therapeutics Market Size by Region (2019-2024)
6.2 APAC Exosome Diagnostics and Therapeutics Market Size by Type (2019-2024)
6.3 APAC Exosome Diagnostics and Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Exosome Diagnostics and Therapeutics by Country (2019-2024)
7.2 Europe Exosome Diagnostics and Therapeutics Market Size by Type (2019-2024)
7.3 Europe Exosome Diagnostics and Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Exosome Diagnostics and Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET FORECAST
10.1 Global Exosome Diagnostics and Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Exosome Diagnostics and Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Exosome Diagnostics and Therapeutics Forecast
10.1.3 APAC Exosome Diagnostics and Therapeutics Forecast
10.1.4 Europe Exosome Diagnostics and Therapeutics Forecast
10.1.5 Middle East & Africa Exosome Diagnostics and Therapeutics Forecast
10.2 Americas Exosome Diagnostics and Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Exosome Diagnostics and Therapeutics Market Forecast
10.2.2 Canada Exosome Diagnostics and Therapeutics Market Forecast
10.2.3 Mexico Exosome Diagnostics and Therapeutics Market Forecast
10.2.4 Brazil Exosome Diagnostics and Therapeutics Market Forecast
10.3 APAC Exosome Diagnostics and Therapeutics Forecast by Region (2025-2030)
10.3.1 China Exosome Diagnostics and Therapeutics Market Forecast
10.3.2 Japan Exosome Diagnostics and Therapeutics Market Forecast
10.3.3 Korea Exosome Diagnostics and Therapeutics Market Forecast
10.3.4 Southeast Asia Exosome Diagnostics and Therapeutics Market Forecast
10.3.5 India Exosome Diagnostics and Therapeutics Market Forecast
10.3.6 Australia Exosome Diagnostics and Therapeutics Market Forecast
10.4 Europe Exosome Diagnostics and Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Exosome Diagnostics and Therapeutics Market Forecast
10.4.2 France Exosome Diagnostics and Therapeutics Market Forecast
10.4.3 UK Exosome Diagnostics and Therapeutics Market Forecast
10.4.4 Italy Exosome Diagnostics and Therapeutics Market Forecast
10.4.5 Russia Exosome Diagnostics and Therapeutics Market Forecast
10.5 Middle East & Africa Exosome Diagnostics and Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Exosome Diagnostics and Therapeutics Market Forecast
10.5.2 South Africa Exosome Diagnostics and Therapeutics Market Forecast
10.5.3 Israel Exosome Diagnostics and Therapeutics Market Forecast
10.5.4 Turkey Exosome Diagnostics and Therapeutics Market Forecast
10.5.5 GCC Countries Exosome Diagnostics and Therapeutics Market Forecast
10.6 Global Exosome Diagnostics and Therapeutics Forecast by Type (2025-2030)
10.7 Global Exosome Diagnostics and Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Aethlon Medical(US)
11.1.1 Aethlon Medical(US) Company Information
11.1.2 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product Offered
11.1.3 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Aethlon Medical(US) Main Business Overview
11.1.5 Aethlon Medical(US) Latest Developments
11.2 Exosome Diagnostics(US)
11.2.1 Exosome Diagnostics(US) Company Information
11.2.2 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product Offered
11.2.3 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Exosome Diagnostics(US) Main Business Overview
11.2.5 Exosome Diagnostics(US) Latest Developments
11.3 NanoSomix Inc.(US)
11.3.1 NanoSomix Inc.(US) Company Information
11.3.2 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product Offered
11.3.3 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 NanoSomix Inc.(US) Main Business Overview
11.3.5 NanoSomix Inc.(US) Latest Developments
11.4 Thermo Fisher Scientific (US)
11.4.1 Thermo Fisher Scientific (US) Company Information
11.4.2 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product Offered
11.4.3 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Thermo Fisher Scientific (US) Main Business Overview
11.4.5 Thermo Fisher Scientific (US) Latest Developments
11.5 Malvern Instruments (UK)
11.5.1 Malvern Instruments (UK) Company Information
11.5.2 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product Offered
11.5.3 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Malvern Instruments (UK) Main Business Overview
11.5.5 Malvern Instruments (UK) Latest Developments
11.6 System Biosciences(US)
11.6.1 System Biosciences(US) Company Information
11.6.2 System Biosciences(US) Exosome Diagnostics and Therapeutics Product Offered
11.6.3 System Biosciences(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 System Biosciences(US) Main Business Overview
11.6.5 System Biosciences(US) Latest Developments
11.7 NX Pharmagen (US)
11.7.1 NX Pharmagen (US) Company Information
11.7.2 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product Offered
11.7.3 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 NX Pharmagen (US) Main Business Overview
11.7.5 NX Pharmagen (US) Latest Developments
11.8 Sistemic Inc(UK)
11.8.1 Sistemic Inc(UK) Company Information
11.8.2 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product Offered
11.8.3 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Sistemic Inc(UK) Main Business Overview
11.8.5 Sistemic Inc(UK) Latest Developments
11.9 Capricor Therapeutics (US)
11.9.1 Capricor Therapeutics (US) Company Information
11.9.2 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product Offered
11.9.3 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Capricor Therapeutics (US) Main Business Overview
11.9.5 Capricor Therapeutics (US) Latest Developments
11.10 Exiqon A/S (Denmark)
11.10.1 Exiqon A/S (Denmark) Company Information
11.10.2 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product Offered
11.10.3 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Exiqon A/S (Denmark) Main Business Overview
11.10.5 Exiqon A/S (Denmark) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Exosome Diagnostics and Therapeutics Market Size 2019-2030
2.1.2 Exosome Diagnostics and Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Exosome Diagnostics and Therapeutics Segment by Type
2.2.1 Instrument
2.2.2 Reagent
2.2.3 Software
2.3 Exosome Diagnostics and Therapeutics Market Size by Type
2.3.1 Exosome Diagnostics and Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Exosome Diagnostics and Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Exosome Diagnostics and Therapeutics Segment by Application
2.4.1 Diagnostic
2.4.2 Therapeutic
2.5 Exosome Diagnostics and Therapeutics Market Size by Application
2.5.1 Exosome Diagnostics and Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Exosome Diagnostics and Therapeutics Market Size Market Share by Application (2019-2024)
3 EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Exosome Diagnostics and Therapeutics Market Size Market Share by Players
3.1.1 Global Exosome Diagnostics and Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Exosome Diagnostics and Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Exosome Diagnostics and Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 EXOSOME DIAGNOSTICS AND THERAPEUTICS BY REGIONS
4.1 Exosome Diagnostics and Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Exosome Diagnostics and Therapeutics Market Size Growth (2019-2024)
4.3 APAC Exosome Diagnostics and Therapeutics Market Size Growth (2019-2024)
4.4 Europe Exosome Diagnostics and Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Exosome Diagnostics and Therapeutics Market Size by Country (2019-2024)
5.2 Americas Exosome Diagnostics and Therapeutics Market Size by Type (2019-2024)
5.3 Americas Exosome Diagnostics and Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Exosome Diagnostics and Therapeutics Market Size by Region (2019-2024)
6.2 APAC Exosome Diagnostics and Therapeutics Market Size by Type (2019-2024)
6.3 APAC Exosome Diagnostics and Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Exosome Diagnostics and Therapeutics by Country (2019-2024)
7.2 Europe Exosome Diagnostics and Therapeutics Market Size by Type (2019-2024)
7.3 Europe Exosome Diagnostics and Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Exosome Diagnostics and Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL EXOSOME DIAGNOSTICS AND THERAPEUTICS MARKET FORECAST
10.1 Global Exosome Diagnostics and Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Exosome Diagnostics and Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Exosome Diagnostics and Therapeutics Forecast
10.1.3 APAC Exosome Diagnostics and Therapeutics Forecast
10.1.4 Europe Exosome Diagnostics and Therapeutics Forecast
10.1.5 Middle East & Africa Exosome Diagnostics and Therapeutics Forecast
10.2 Americas Exosome Diagnostics and Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Exosome Diagnostics and Therapeutics Market Forecast
10.2.2 Canada Exosome Diagnostics and Therapeutics Market Forecast
10.2.3 Mexico Exosome Diagnostics and Therapeutics Market Forecast
10.2.4 Brazil Exosome Diagnostics and Therapeutics Market Forecast
10.3 APAC Exosome Diagnostics and Therapeutics Forecast by Region (2025-2030)
10.3.1 China Exosome Diagnostics and Therapeutics Market Forecast
10.3.2 Japan Exosome Diagnostics and Therapeutics Market Forecast
10.3.3 Korea Exosome Diagnostics and Therapeutics Market Forecast
10.3.4 Southeast Asia Exosome Diagnostics and Therapeutics Market Forecast
10.3.5 India Exosome Diagnostics and Therapeutics Market Forecast
10.3.6 Australia Exosome Diagnostics and Therapeutics Market Forecast
10.4 Europe Exosome Diagnostics and Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Exosome Diagnostics and Therapeutics Market Forecast
10.4.2 France Exosome Diagnostics and Therapeutics Market Forecast
10.4.3 UK Exosome Diagnostics and Therapeutics Market Forecast
10.4.4 Italy Exosome Diagnostics and Therapeutics Market Forecast
10.4.5 Russia Exosome Diagnostics and Therapeutics Market Forecast
10.5 Middle East & Africa Exosome Diagnostics and Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Exosome Diagnostics and Therapeutics Market Forecast
10.5.2 South Africa Exosome Diagnostics and Therapeutics Market Forecast
10.5.3 Israel Exosome Diagnostics and Therapeutics Market Forecast
10.5.4 Turkey Exosome Diagnostics and Therapeutics Market Forecast
10.5.5 GCC Countries Exosome Diagnostics and Therapeutics Market Forecast
10.6 Global Exosome Diagnostics and Therapeutics Forecast by Type (2025-2030)
10.7 Global Exosome Diagnostics and Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Aethlon Medical(US)
11.1.1 Aethlon Medical(US) Company Information
11.1.2 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product Offered
11.1.3 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Aethlon Medical(US) Main Business Overview
11.1.5 Aethlon Medical(US) Latest Developments
11.2 Exosome Diagnostics(US)
11.2.1 Exosome Diagnostics(US) Company Information
11.2.2 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product Offered
11.2.3 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Exosome Diagnostics(US) Main Business Overview
11.2.5 Exosome Diagnostics(US) Latest Developments
11.3 NanoSomix Inc.(US)
11.3.1 NanoSomix Inc.(US) Company Information
11.3.2 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product Offered
11.3.3 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 NanoSomix Inc.(US) Main Business Overview
11.3.5 NanoSomix Inc.(US) Latest Developments
11.4 Thermo Fisher Scientific (US)
11.4.1 Thermo Fisher Scientific (US) Company Information
11.4.2 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product Offered
11.4.3 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Thermo Fisher Scientific (US) Main Business Overview
11.4.5 Thermo Fisher Scientific (US) Latest Developments
11.5 Malvern Instruments (UK)
11.5.1 Malvern Instruments (UK) Company Information
11.5.2 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product Offered
11.5.3 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Malvern Instruments (UK) Main Business Overview
11.5.5 Malvern Instruments (UK) Latest Developments
11.6 System Biosciences(US)
11.6.1 System Biosciences(US) Company Information
11.6.2 System Biosciences(US) Exosome Diagnostics and Therapeutics Product Offered
11.6.3 System Biosciences(US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 System Biosciences(US) Main Business Overview
11.6.5 System Biosciences(US) Latest Developments
11.7 NX Pharmagen (US)
11.7.1 NX Pharmagen (US) Company Information
11.7.2 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product Offered
11.7.3 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 NX Pharmagen (US) Main Business Overview
11.7.5 NX Pharmagen (US) Latest Developments
11.8 Sistemic Inc(UK)
11.8.1 Sistemic Inc(UK) Company Information
11.8.2 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product Offered
11.8.3 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Sistemic Inc(UK) Main Business Overview
11.8.5 Sistemic Inc(UK) Latest Developments
11.9 Capricor Therapeutics (US)
11.9.1 Capricor Therapeutics (US) Company Information
11.9.2 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product Offered
11.9.3 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Capricor Therapeutics (US) Main Business Overview
11.9.5 Capricor Therapeutics (US) Latest Developments
11.10 Exiqon A/S (Denmark)
11.10.1 Exiqon A/S (Denmark) Company Information
11.10.2 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product Offered
11.10.3 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Exiqon A/S (Denmark) Main Business Overview
11.10.5 Exiqon A/S (Denmark) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Exosome Diagnostics and Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Instrument
Table 3. Major Players of Reagent
Table 4. Major Players of Software
Table 5. Exosome Diagnostics and Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Exosome Diagnostics and Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Exosome Diagnostics and Therapeutics Market Size Market Share by Type (2019-2024)
Table 8. Exosome Diagnostics and Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Exosome Diagnostics and Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Exosome Diagnostics and Therapeutics Market Size Market Share by Application (2019-2024)
Table 11. Global Exosome Diagnostics and Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Player (2019-2024)
Table 13. Exosome Diagnostics and Therapeutics Key Players Head office and Products Offered
Table 14. Exosome Diagnostics and Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Exosome Diagnostics and Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Exosome Diagnostics and Therapeutics Market Size Market Share by Regions (2019-2024)
Table 19. Global Exosome Diagnostics and Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Exosome Diagnostics and Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Exosome Diagnostics and Therapeutics Market Size Market Share by Country (2019-2024)
Table 23. Americas Exosome Diagnostics and Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Exosome Diagnostics and Therapeutics Market Size Market Share by Type (2019-2024)
Table 25. Americas Exosome Diagnostics and Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Exosome Diagnostics and Therapeutics Market Size Market Share by Application (2019-2024)
Table 27. APAC Exosome Diagnostics and Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Exosome Diagnostics and Therapeutics Market Size Market Share by Region (2019-2024)
Table 29. APAC Exosome Diagnostics and Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Exosome Diagnostics and Therapeutics Market Size Market Share by Type (2019-2024)
Table 31. APAC Exosome Diagnostics and Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Exosome Diagnostics and Therapeutics Market Size Market Share by Application (2019-2024)
Table 33. Europe Exosome Diagnostics and Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Exosome Diagnostics and Therapeutics Market Size Market Share by Country (2019-2024)
Table 35. Europe Exosome Diagnostics and Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Exosome Diagnostics and Therapeutics Market Size Market Share by Type (2019-2024)
Table 37. Europe Exosome Diagnostics and Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Exosome Diagnostics and Therapeutics Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Exosome Diagnostics and Therapeutics
Table 46. Key Market Challenges & Risks of Exosome Diagnostics and Therapeutics
Table 47. Key Industry Trends of Exosome Diagnostics and Therapeutics
Table 48. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Exosome Diagnostics and Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Aethlon Medical(US) Details, Company Type, Exosome Diagnostics and Therapeutics Area Served and Its Competitors
Table 53. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product Offered
Table 54. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Aethlon Medical(US) Main Business
Table 56. Aethlon Medical(US) Latest Developments
Table 57. Exosome Diagnostics(US) Details, Company Type, Exosome Diagnostics and Therapeutics Area Served and Its Competitors
Table 58. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product Offered
Table 59. Exosome Diagnostics(US) Main Business
Table 60. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Exosome Diagnostics(US) Latest Developments
Table 62. NanoSomix Inc.(US) Details, Company Type, Exosome Diagnostics and Therapeutics Area Served and Its Competitors
Table 63. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product Offered
Table 64. NanoSomix Inc.(US) Main Business
Table 65. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. NanoSomix Inc.(US) Latest Developments
Table 67. Thermo Fisher Scientific (US) Details, Company Type, Exosome Diagnostics and Therapeutics Area Served and Its Competitors
Table 68. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product Offered
Table 69. Thermo Fisher Scientific (US) Main Business
Table 70. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Thermo Fisher Scientific (US) Latest Developments
Table 72. Malvern Instruments (UK) Details, Company Type, Exosome Diagnostics and Therapeutics Area Served and Its Competitors
Table 73. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product Offered
Table 74. Malvern Instruments (UK) Main Business
Table 75. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Malvern Instruments (UK) Latest Developments
Table 77. System Biosciences(US) Details, Company Type, Exosome Diagnostics and Therapeutics Area Served and Its Competitors
Table 78. System Biosciences(US) Exosome Diagnostics and Therapeutics Product Offered
Table 79. System Biosciences(US) Main Business
Table 80. System Biosciences(US) Exosome Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. System Biosciences(US) Latest Developments
Table 82. NX Pharmagen (US) Details, Company Type, Exosome Diagnostics and Therapeutics Area Served and Its Competitors
Table 83. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product Offered
Table 84. NX Pharmagen (US) Main Business
Table 85. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. NX Pharmagen (US) Latest Developments
Table 87. Sistemic Inc(UK) Details, Company Type, Exosome Diagnostics and Therapeutics Area Served and Its Competitors
Table 88. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product Offered
Table 89. Sistemic Inc(UK) Main Business
Table 90. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Sistemic Inc(UK) Latest Developments
Table 92. Capricor Therapeutics (US) Details, Company Type, Exosome Diagnostics and Therapeutics Area Served and Its Competitors
Table 93. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product Offered
Table 94. Capricor Therapeutics (US) Main Business
Table 95. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Capricor Therapeutics (US) Latest Developments
Table 97. Exiqon A/S (Denmark) Details, Company Type, Exosome Diagnostics and Therapeutics Area Served and Its Competitors
Table 98. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product Offered
Table 99. Exiqon A/S (Denmark) Main Business
Table 100. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Exiqon A/S (Denmark) Latest Developments
Table 1. Exosome Diagnostics and Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Instrument
Table 3. Major Players of Reagent
Table 4. Major Players of Software
Table 5. Exosome Diagnostics and Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Exosome Diagnostics and Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Exosome Diagnostics and Therapeutics Market Size Market Share by Type (2019-2024)
Table 8. Exosome Diagnostics and Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Exosome Diagnostics and Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Exosome Diagnostics and Therapeutics Market Size Market Share by Application (2019-2024)
Table 11. Global Exosome Diagnostics and Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Player (2019-2024)
Table 13. Exosome Diagnostics and Therapeutics Key Players Head office and Products Offered
Table 14. Exosome Diagnostics and Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Exosome Diagnostics and Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Exosome Diagnostics and Therapeutics Market Size Market Share by Regions (2019-2024)
Table 19. Global Exosome Diagnostics and Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Exosome Diagnostics and Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Exosome Diagnostics and Therapeutics Market Size Market Share by Country (2019-2024)
Table 23. Americas Exosome Diagnostics and Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Exosome Diagnostics and Therapeutics Market Size Market Share by Type (2019-2024)
Table 25. Americas Exosome Diagnostics and Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Exosome Diagnostics and Therapeutics Market Size Market Share by Application (2019-2024)
Table 27. APAC Exosome Diagnostics and Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Exosome Diagnostics and Therapeutics Market Size Market Share by Region (2019-2024)
Table 29. APAC Exosome Diagnostics and Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Exosome Diagnostics and Therapeutics Market Size Market Share by Type (2019-2024)
Table 31. APAC Exosome Diagnostics and Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Exosome Diagnostics and Therapeutics Market Size Market Share by Application (2019-2024)
Table 33. Europe Exosome Diagnostics and Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Exosome Diagnostics and Therapeutics Market Size Market Share by Country (2019-2024)
Table 35. Europe Exosome Diagnostics and Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Exosome Diagnostics and Therapeutics Market Size Market Share by Type (2019-2024)
Table 37. Europe Exosome Diagnostics and Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Exosome Diagnostics and Therapeutics Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Exosome Diagnostics and Therapeutics
Table 46. Key Market Challenges & Risks of Exosome Diagnostics and Therapeutics
Table 47. Key Industry Trends of Exosome Diagnostics and Therapeutics
Table 48. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Exosome Diagnostics and Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Exosome Diagnostics and Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Aethlon Medical(US) Details, Company Type, Exosome Diagnostics and Therapeutics Area Served and Its Competitors
Table 53. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product Offered
Table 54. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Aethlon Medical(US) Main Business
Table 56. Aethlon Medical(US) Latest Developments
Table 57. Exosome Diagnostics(US) Details, Company Type, Exosome Diagnostics and Therapeutics Area Served and Its Competitors
Table 58. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product Offered
Table 59. Exosome Diagnostics(US) Main Business
Table 60. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Exosome Diagnostics(US) Latest Developments
Table 62. NanoSomix Inc.(US) Details, Company Type, Exosome Diagnostics and Therapeutics Area Served and Its Competitors
Table 63. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product Offered
Table 64. NanoSomix Inc.(US) Main Business
Table 65. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. NanoSomix Inc.(US) Latest Developments
Table 67. Thermo Fisher Scientific (US) Details, Company Type, Exosome Diagnostics and Therapeutics Area Served and Its Competitors
Table 68. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product Offered
Table 69. Thermo Fisher Scientific (US) Main Business
Table 70. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Thermo Fisher Scientific (US) Latest Developments
Table 72. Malvern Instruments (UK) Details, Company Type, Exosome Diagnostics and Therapeutics Area Served and Its Competitors
Table 73. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product Offered
Table 74. Malvern Instruments (UK) Main Business
Table 75. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Malvern Instruments (UK) Latest Developments
Table 77. System Biosciences(US) Details, Company Type, Exosome Diagnostics and Therapeutics Area Served and Its Competitors
Table 78. System Biosciences(US) Exosome Diagnostics and Therapeutics Product Offered
Table 79. System Biosciences(US) Main Business
Table 80. System Biosciences(US) Exosome Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. System Biosciences(US) Latest Developments
Table 82. NX Pharmagen (US) Details, Company Type, Exosome Diagnostics and Therapeutics Area Served and Its Competitors
Table 83. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product Offered
Table 84. NX Pharmagen (US) Main Business
Table 85. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. NX Pharmagen (US) Latest Developments
Table 87. Sistemic Inc(UK) Details, Company Type, Exosome Diagnostics and Therapeutics Area Served and Its Competitors
Table 88. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product Offered
Table 89. Sistemic Inc(UK) Main Business
Table 90. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. Sistemic Inc(UK) Latest Developments
Table 92. Capricor Therapeutics (US) Details, Company Type, Exosome Diagnostics and Therapeutics Area Served and Its Competitors
Table 93. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product Offered
Table 94. Capricor Therapeutics (US) Main Business
Table 95. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Capricor Therapeutics (US) Latest Developments
Table 97. Exiqon A/S (Denmark) Details, Company Type, Exosome Diagnostics and Therapeutics Area Served and Its Competitors
Table 98. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product Offered
Table 99. Exiqon A/S (Denmark) Main Business
Table 100. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Exiqon A/S (Denmark) Latest Developments
LIST OF FIGURES
Figure 1. Exosome Diagnostics and Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Exosome Diagnostics and Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Exosome Diagnostics and Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Exosome Diagnostics and Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Exosome Diagnostics and Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Exosome Diagnostics and Therapeutics Market Size Market Share by Type in 2023
Figure 10. Exosome Diagnostics and Therapeutics in Diagnostic
Figure 11. Global Exosome Diagnostics and Therapeutics Market: Diagnostic (2019-2024) & ($ Millions)
Figure 12. Exosome Diagnostics and Therapeutics in Therapeutic
Figure 13. Global Exosome Diagnostics and Therapeutics Market: Therapeutic (2019-2024) & ($ Millions)
Figure 14. Global Exosome Diagnostics and Therapeutics Market Size Market Share by Application in 2023
Figure 15. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Player in 2023
Figure 16. Global Exosome Diagnostics and Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Exosome Diagnostics and Therapeutics Market Size 2019-2024 ($ Millions)
Figure 18. APAC Exosome Diagnostics and Therapeutics Market Size 2019-2024 ($ Millions)
Figure 19. Europe Exosome Diagnostics and Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Americas Exosome Diagnostics and Therapeutics Value Market Share by Country in 2023
Figure 22. United States Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Exosome Diagnostics and Therapeutics Market Size Market Share by Region in 2023
Figure 27. APAC Exosome Diagnostics and Therapeutics Market Size Market Share by Type in 2023
Figure 28. APAC Exosome Diagnostics and Therapeutics Market Size Market Share by Application in 2023
Figure 29. China Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Exosome Diagnostics and Therapeutics Market Size Market Share by Country in 2023
Figure 36. Europe Exosome Diagnostics and Therapeutics Market Size Market Share by Type (2019-2024)
Figure 37. Europe Exosome Diagnostics and Therapeutics Market Size Market Share by Application (2019-2024)
Figure 38. Germany Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 52. APAC Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 53. Europe Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. United States Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Canada Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. China Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Japan Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. Korea Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. India Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Australia Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. Germany Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. France Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. UK Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Italy Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. Russia Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Spain Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Israel Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Global Exosome Diagnostics and Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Exosome Diagnostics and Therapeutics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Exosome Diagnostics and Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Exosome Diagnostics and Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Exosome Diagnostics and Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Exosome Diagnostics and Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Exosome Diagnostics and Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Exosome Diagnostics and Therapeutics Market Size Market Share by Type in 2023
Figure 10. Exosome Diagnostics and Therapeutics in Diagnostic
Figure 11. Global Exosome Diagnostics and Therapeutics Market: Diagnostic (2019-2024) & ($ Millions)
Figure 12. Exosome Diagnostics and Therapeutics in Therapeutic
Figure 13. Global Exosome Diagnostics and Therapeutics Market: Therapeutic (2019-2024) & ($ Millions)
Figure 14. Global Exosome Diagnostics and Therapeutics Market Size Market Share by Application in 2023
Figure 15. Global Exosome Diagnostics and Therapeutics Revenue Market Share by Player in 2023
Figure 16. Global Exosome Diagnostics and Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Exosome Diagnostics and Therapeutics Market Size 2019-2024 ($ Millions)
Figure 18. APAC Exosome Diagnostics and Therapeutics Market Size 2019-2024 ($ Millions)
Figure 19. Europe Exosome Diagnostics and Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Americas Exosome Diagnostics and Therapeutics Value Market Share by Country in 2023
Figure 22. United States Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Exosome Diagnostics and Therapeutics Market Size Market Share by Region in 2023
Figure 27. APAC Exosome Diagnostics and Therapeutics Market Size Market Share by Type in 2023
Figure 28. APAC Exosome Diagnostics and Therapeutics Market Size Market Share by Application in 2023
Figure 29. China Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Exosome Diagnostics and Therapeutics Market Size Market Share by Country in 2023
Figure 36. Europe Exosome Diagnostics and Therapeutics Market Size Market Share by Type (2019-2024)
Figure 37. Europe Exosome Diagnostics and Therapeutics Market Size Market Share by Application (2019-2024)
Figure 38. Germany Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Exosome Diagnostics and Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 52. APAC Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 53. Europe Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. United States Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Canada Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. China Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Japan Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. Korea Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. India Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Australia Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. Germany Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. France Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. UK Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Italy Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. Russia Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Spain Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Israel Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Exosome Diagnostics and Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Global Exosome Diagnostics and Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Exosome Diagnostics and Therapeutics Market Size Market Share Forecast by Application (2025-2030)
